UniProt ID | C2TA_HUMAN | |
---|---|---|
UniProt AC | P33076 | |
Protein Name | MHC class II transactivator | |
Gene Name | CIITA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1130 | |
Subcellular Localization | Nucleus . Nucleus, PML body . Recruited to PML body by PML. | |
Protein Description | Essential for transcriptional activity of the HLA class II promoter; activation is via the proximal promoter. No DNA binding of in vitro translated CIITA was detected. May act in a coactivator-like fashion through protein-protein interactions by contacting factors binding to the proximal MHC class II promoter, to elements of the transcription machinery, or both. Alternatively it may activate HLA class II transcription by modifying proteins that bind to the MHC class II promoter. Also mediates enhanced MHC class I transcription; the promoter element requirements for CIITA-mediated transcription are distinct from those of constitutive MHC class I transcription, and CIITA can functionally replace TAF1 at these genes. Exhibits intrinsic GTP-stimulated acetyltransferase activity. Exhibits serine/threonine protein kinase activity: can phosphorylate the TFIID component TAF7, the RAP74 subunit of the general transcription factor TFIIF, histone H2B at 'Ser-37' and other histones (in vitro).. | |
Protein Sequence | MRCLAPRPAGSYLSEPQGSSQCATMELGPLEGGYLELLNSDADPLCLYHFYDQMDLAGEEEIELYSEPDTDTINCDQFSRLLCDMEGDEETREAYANIAELDQYVFQDSQLEGLSKDIFKHIGPDEVIGESMEMPAEVGQKSQKRPFPEELPADLKHWKPAEPPTVVTGSLLVRPVSDCSTLPCLPLPALFNQEPASGQMRLEKTDQIPMPFSSSSLSCLNLPEGPIQFVPTISTLPHGLWQISEAGTGVSSIFIYHGEVPQASQVPPPSGFTVHGLPTSPDRPGSTSPFAPSATDLPSMPEPALTSRANMTEHKTSPTQCPAAGEVSNKLPKWPEPVEQFYRSLQDTYGAEPAGPDGILVEVDLVQARLERSSSKSLERELATPDWAERQLAQGGLAEVLLAAKEHRRPRETRVIAVLGKAGQGKSYWAGAVSRAWACGRLPQYDFVFSVPCHCLNRPGDAYGLQDLLFSLGPQPLVAADEVFSHILKRPDRVLLILDGFEELEAQDGFLHSTCGPAPAEPCSLRGLLAGLFQKKLLRGCTLLLTARPRGRLVQSLSKADALFELSGFSMEQAQAYVMRYFESSGMTEHQDRALTLLRDRPLLLSHSHSPTLCRAVCQLSEALLELGEDAKLPSTLTGLYVGLLGRAALDSPPGALAELAKLAWELGRRHQSTLQEDQFPSADVRTWAMAKGLVQHPPRAAESELAFPSFLLQCFLGALWLALSGEIKDKELPQYLALTPRKKRPYDNWLEGVPRFLAGLIFQPPARCLGALLGPSAAASVDRKQKVLARYLKRLQPGTLRARQLLELLHCAHEAEEAGIWQHVVQELPGRLSFLGTRLTPPDAHVLGKALEAAGQDFSLDLRSTGICPSGLGSLVGLSCVTRFRAALSDTVALWESLQQHGETKLLQAAEEKFTIEPFKAKSLKDVEDLGKLVQTQRTRSSSEDTAGELPAVRDLKKLEFALGPVSGPQAFPKLVRILTAFSSLQHLDLDALSENKIGDEGVSQLSATFPQLKSLETLNLSQNNITDLGAYKLAEALPSLAASLLRLSLYNNCICDVGAESLARVLPDMVSLRVMDVQYNKFTAAGAQQLAASLRRCPHVETLAMWTPTIPFSVQEHLQQQDSRISLR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
95 | Phosphorylation | DEETREAYANIAELD CHHHHHHHHHHHHHH | 8.74 | 22210691 | |
104 | Phosphorylation | NIAELDQYVFQDSQL HHHHHHHHHHCCHHH | 11.69 | 22210691 | |
109 | Phosphorylation | DQYVFQDSQLEGLSK HHHHHCCHHHCCCCH | 26.36 | 22210691 | |
141 | Acetylation | MPAEVGQKSQKRPFP CCHHHCCCCCCCCCC | 49.26 | 11046145 | |
144 | Acetylation | EVGQKSQKRPFPEEL HHCCCCCCCCCCCCC | 69.95 | 11514574 | |
280 | Phosphorylation | TVHGLPTSPDRPGST EEECCCCCCCCCCCC | 23.90 | 20538595 | |
286 | Phosphorylation | TSPDRPGSTSPFAPS CCCCCCCCCCCCCCC | 28.52 | 15210796 | |
287 | Phosphorylation | SPDRPGSTSPFAPSA CCCCCCCCCCCCCCC | 46.46 | 29449344 | |
288 | Phosphorylation | PDRPGSTSPFAPSAT CCCCCCCCCCCCCCC | 21.51 | 23663014 | |
293 | Phosphorylation | STSPFAPSATDLPSM CCCCCCCCCCCCCCC | 40.13 | 15210796 | |
315 | Ubiquitination | RANMTEHKTSPTQCP CCCCCCCCCCCCCCC | 44.45 | 20538595 | |
330 | Ubiquitination | AAGEVSNKLPKWPEP CCHHHCCCCCCCCCH | 59.67 | 20538595 | |
333 | Ubiquitination | EVSNKLPKWPEPVEQ HHCCCCCCCCCHHHH | 82.74 | 2053859 | |
373 | Phosphorylation | VQARLERSSSKSLER HHHHHHHCCCHHHHH | 29.59 | 17991736 | |
427 | Phosphorylation | GKAGQGKSYWAGAVS ECCCCCHHHHHHHHH | 32.50 | - | |
428 | Phosphorylation | KAGQGKSYWAGAVSR CCCCCHHHHHHHHHH | 11.63 | - | |
434 | Phosphorylation | SYWAGAVSRAWACGR HHHHHHHHHHHHCCC | 18.75 | - | |
536 | Ubiquitination | LAGLFQKKLLRGCTL HHHHHHHHHHCCCEE | 41.81 | - | |
546 | Phosphorylation | RGCTLLLTARPRGRL CCCEEEEEECCCCHH | 22.16 | - | |
740 | Phosphorylation | LPQYLALTPRKKRPY CCHHHHCCCCCCCCC | 18.55 | 24719451 | |
834 | Phosphorylation | QELPGRLSFLGTRLT HHCCCCCEECCCCCC | 19.64 | 21712546 | |
838 | Phosphorylation | GRLSFLGTRLTPPDA CCCEECCCCCCCCCH | 25.34 | 21712546 | |
916 | O-linked_Glycosylation | QAAEEKFTIEPFKAK HHHHHCCCCCCCCCC | 35.18 | 30379171 | |
942 | Phosphorylation | VQTQRTRSSSEDTAG HHHHHHCCCCCCCCC | 37.29 | 25002506 | |
943 | Phosphorylation | QTQRTRSSSEDTAGE HHHHHCCCCCCCCCC | 34.16 | 25002506 | |
944 | Phosphorylation | TQRTRSSSEDTAGEL HHHHCCCCCCCCCCC | 40.51 | 26670566 | |
947 | Phosphorylation | TRSSSEDTAGELPAV HCCCCCCCCCCCCCH | 32.29 | 25002506 | |
959 | Acetylation | PAVRDLKKLEFALGP CCHHHHHHCCHHCCC | 61.62 | 156323 | |
1016 | Phosphorylation | ATFPQLKSLETLNLS CCCHHHCCCCCCCCC | 39.78 | 29083192 | |
1019 | Phosphorylation | PQLKSLETLNLSQNN HHHCCCCCCCCCCCC | 26.66 | 29083192 | |
1023 | Phosphorylation | SLETLNLSQNNITDL CCCCCCCCCCCCCHH | 29.77 | 29116813 | |
1028 | Phosphorylation | NLSQNNITDLGAYKL CCCCCCCCHHHHHHH | 27.56 | 29083192 | |
1033 | Phosphorylation | NITDLGAYKLAEALP CCCHHHHHHHHHHHH | 12.53 | 29083192 | |
1045 | Phosphorylation | ALPSLAASLLRLSLY HHHHHHHHHHHHHHH | 23.48 | 24719451 | |
1050 | Phosphorylation | AASLLRLSLYNNCIC HHHHHHHHHHCCCCC | 23.52 | 11416140 | |
1073 | O-linked_Glycosylation | RVLPDMVSLRVMDVQ HHCCCCCEEEEEECC | 12.10 | 30379171 | |
1073 | Phosphorylation | RVLPDMVSLRVMDVQ HHCCCCCEEEEEECC | 12.10 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
280 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
280 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
288 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
288 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
373 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
834 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
834 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
834 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
1050 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
1050 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
1050 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
1128 | S | Phosphorylation | Kinase | PRKACA | P17252 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | MARCHF8 | Q5T0T0 | PMID:19566897 |
- | K | Ubiquitination | E3 ubiquitin ligase | MARCHF1 | Q8TCQ1 | PMID:19880452 |
- | K | Ubiquitination | E3 ubiquitin ligase | MARCHF5 | Q9NX47 | PMID:18389477 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of C2TA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of C2TA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NCOA1_HUMAN | NCOA1 | physical | 12933903 | |
RFX5_HUMAN | RFX5 | physical | 11003667 | |
RFXK_HUMAN | RFXANK | physical | 11003667 | |
MK03_HUMAN | MAPK3 | physical | 18245089 | |
MK01_HUMAN | MAPK1 | physical | 18245089 | |
HDAC2_HUMAN | HDAC2 | physical | 19041327 | |
SMCA4_HUMAN | SMARCA4 | physical | 12077331 | |
HDAC4_HUMAN | HDAC4 | physical | 15964851 | |
HDAC2_HUMAN | HDAC2 | physical | 17991736 | |
SIN3B_HUMAN | SIN3B | physical | 17991736 | |
TF2B_HUMAN | GTF2B | physical | 9177216 | |
TAF9_HUMAN | TAF9 | physical | 9177216 | |
PRS8_HUMAN | PSMC5 | physical | 18215421 | |
PPARG_HUMAN | PPARG | physical | 17611194 | |
EP300_HUMAN | EP300 | physical | 26871568 | |
EP400_HUMAN | EP400 | physical | 26871568 | |
TBP_HUMAN | TBP | physical | 26871568 | |
RFX5_HUMAN | RFX5 | physical | 26871568 | |
PRS8_HUMAN | PSMC5 | physical | 26871568 | |
PML_HUMAN | PML | physical | 28555140 | |
CCNT1_HUMAN | CCNT1 | physical | 28555140 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
209920 | Bare lymphocyte syndrome 2 (BLS2) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...